Corporate / CVC · 3 deals
Every published round Renew Pharmaceuticals took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
Companies Renew Pharmaceuticals has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Ferronova | 23 Jan 2023, Series A | 2 | 2 | |
| FerronovaPrecision cancer treatment technology | 17 Dec 2025, Series A | 1 | 1 |
Fund closes reported for Renew Pharmaceuticals, as distinct from the investments it has made.
Companies Renew Pharmaceuticals has backed that another company then bought. An exit for the holding, not a deal Renew Pharmaceuticals did.
| Name | Role | Sources |
|---|---|---|
| Declan Cassells | COO | Biotech Dispatch, Startup Daily, ferronova.com.au |
| Fidelma Callanan | Head of Marketing, Comms and EMEA Sales | ferronova.com.au |
Stories naming Renew Pharmaceuticals. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Roundup of seven trans-Tasman raises worth $93.1m this week, headlined by IND Technology's $50m round, with LawVu also acquiring ClauseBase.
Adelaide medtech Ferronova has banked another $6 million from returning backers to advance its surgical tracer for cancer, lifting Series A funding to $17.5 million; backer parent UltraGreen.ai floated in Singapore this month.
Also movefm.com.au
Adelaide biotech Ferronova added $6 million to its Series A from prior backers, lifting the round's total to $17.5 million; backer Renew's parent Ultragreen.ai floated in Singapore this month.
Also ferronova.com.au·movefm.com.au·Biotech Dispatch·Startup Daily
Weekly roundup covering three Australian raises: Rumin8's climate tech funding led by Breakthrough Energy Ventures, Ferronova's biotech round led by Renew Pharmaceuticals, and EMVision's stroke imaging milestone payment.
Adelaide biotech Ferronova raised $11 million for its cancer-detection nanotechnology, with Renew Pharmaceuticals and a government CRC contributing, following an earlier $4.6 million Series A in 2020.
Also SmartCompany
Adelaide cancer-focused biotech Ferronova has secured fresh backing: an investor round led by Irish strategic partner Renew Pharmaceuticals plus a federal research grant, to speed clinical trials in stomach and brain cancers.
Also SmartCompany·SmartCompany·SmartCompany·Startup Daily·Business News Australia·Startup Daily
Adelaide biotech Ferronova announced an A$11 million package: an A$8 million round led by Ireland's Renew Pharmaceuticals plus an A$3 million government CRC-P grant, with existing shareholders Uniseed and Artesian also participating.